http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101200402-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-726 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 |
filingDate | 2011-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2012-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2012-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101200402-B1 |
titleOfInvention | Method for producing novel insect glycozyminoglycans |
abstract | The present invention relates to the use of insect glycozaminoglycans for anti-inflammatory, antidiabetic, anticoagulant, anticancer, antiangiogenic use, and / or disease treatment and / or prophylaxis due to dysfunction of vasodilatation and insectglycozymino Provided is a method for preparing glycan. Insect glycosaminoglycans of the present invention can treat and / or prevent diseases caused by dysfunction of anti-inflammatory, anti-diabetic, anticoagulant, anti-cancer, angiogenesis, and / or vasodilation reactions, and the preparation of the present invention. Insect glycosaminoglycans can be effectively produced by the method. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210055475-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101546752-B1 |
priorityDate | 2011-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 273.